If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Exercise of options

13 Nov 2019 08:33

RNS Number : 2426T
Surface Transforms PLC
13 November 2019
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Surface Transforms plc

("Surface Transforms" or the "Company")

 

Exercise of Options

 

Surface Transforms plc (AIM: SCE) announces that the Company was notified on 11 November 2019 that an employee has exercised options over a total of 20,000 ordinary shares of 1p each in the Company ("Ordinary Shares").

 

Specifically, on 8 November 2019, an employee exercised options over 20,000 Ordinary Shares at a price of 15.25p per Ordinary Share.

 

Admission and Total Voting Rights

 

The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 20,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8.00 a.m. on 15 November 2019. Following Admission, the total number of voting rights in the Company will be 136,099,016 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

- Ends -

 

For enquiries, please contact:

 

 

Surface Transforms plc

Kevin Johnson, CEO

+44 151 356 2141

Michael Cunningham CFO

+44 151 348 8882

David Bundred, Chairman

+44 7785 388 848

Cantor Fitzgerald Europe (Nomad & Joint-Broker)

David Foreman, Michael Boot (Corporate Finance)

Caspar Shand Kydd, Maisie Atkinson (Sales)

+44 20 7894 7000

 

FinnCap Ltd (Joint-Broker)

Richard Chambers (Corporate Broking)

Ed Frisby / Giles Rolls (Corporate Finance)

 

+44 20 7220 0500

 

For further Company details, visit www.surfacetransforms.com.

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEGGGMPGUPBURW
Date   Source Headline
17th Aug 20225:48 pmRNSExercise of options
13th Jul 20227:00 amRNSGrant of Options
6th Jul 20227:00 amRNSTrading Statement & Sales and Operations Update
30th Jun 20226:21 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement and Sales & Operations Presentation
21st Jun 20227:00 amRNSAdditional Capital Markets Day & Presentation
27th May 20222:46 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSDirector/PDMR Shareholding
23rd May 202210:58 amRNSPosting of Annual Report and Notice of AGM
10th May 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms’ Capital Markets Day presentation with the Board
6th May 202210:43 amRNSPresentation to Mello Investor evening
25th Apr 20224:05 pmEQSHardman & Co Research: Surface Transforms (SCE) Growth rate and visibility enhanced even further
22nd Apr 20227:00 amRNSSurface Transforms plc Ian Cleminson appointment
11th Apr 202211:00 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
4th Apr 20227:00 amRNSPreliminary Results and Notice of AGM
31st Mar 20227:00 amRNSAdditional Capital Markets Day
24th Mar 20229:05 amRNSSecond Price Monitoring Extn
24th Mar 20229:00 amRNSPrice Monitoring Extension
24th Mar 20227:01 amRNSCapital Markets Day
24th Mar 20227:00 amRNSNew OEM 8 Contract for Additional Sales
18th Feb 20227:00 amRNSExercise of options
28th Jan 20227:00 amRNSTrading and operations update
16th Dec 202112:34 pmRNSMichael Cunningham purchase of shares
16th Dec 20217:00 amRNSAnnouncement of contract wins with OEM 6
14th Dec 20217:00 amRNSTrading and operations update
11th Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20214:35 pmEQSHardman & Co Research : Hardman Talks Video | Surface Transforms Management Presentation
13th Sep 20217:00 amRNSHalf-year Financial Report
2nd Sep 20217:01 amRNSNew manufacturing strategy
2nd Sep 20217:00 amRNSContract Award from OEM 5
17th Aug 20217:00 amRNSContract award from OEM 10 and notice of results
8th Jul 20217:00 amRNSTrading and operations update
5th Jul 20213:00 pmRNSExercise of options
9th Jun 20218:45 amEQSHardman & Co Research : Hardman Talks Video| Surface Transforms Management Presentation
2nd Jun 20219:43 amRNSResult of Annual General Meeting
28th May 202111:18 amRNSExercise of Options
27th May 202111:51 amRNSMeet the Directors and Q&A
25th May 20217:00 amRNSDirector Dealing
20th May 20219:30 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms - Q&A with the Board
13th May 20217:00 amRNSDirector Dealing
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Apr 20215:38 pmRNSPDMR Dealing
22nd Apr 20215:33 pmRNSDirector Dealing
19th Apr 20215:46 pmRNSExercise of Options
13th Apr 20217:00 amRNSDirector Dealing
12th Apr 20217:00 amRNSPreliminary Results and Notice of AGM
24th Mar 20217:00 amRNS£1 million loan agreement with LCRCA
15th Mar 20213:55 pmEQSHardman & Co Research: Surface Transforms (SCE): Everything has come together
15th Mar 20217:00 amRNSRetirement of NED & update on preliminary results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.